Navigation Links
Nearly half of children under 2 years of age receive some vaccinations late
Date:1/21/2013

DENVER, January 21, 2013 In a new study published today in JAMA Pediatrics (formerly Archives of Pediatrics and Adolescent Medicine), Kaiser Permanente researchers found that 49 percent of children ages 2-24 months did not receive all recommended vaccinations or did not get vaccinated according to the Advisory Committee on Immunization Practices schedule.

Kaiser Permanente researchers used the Vaccine Safety Datalink a collaborative effort among the Centers for Disease Control and Prevention and nine managed care organizations to analyze immunization records of 323,247 children born between 2004. Data from immunization records helped illuminate the number of days each child was missing scheduled vaccines for any reason, including parents intentionally choosing not to vaccinate their children according to ACIP recommendations. Children who did not receive their vaccines on time were considered "undervaccinated."

"While a large majority of parents in the US choose to vaccinate their children, a growing number of parents are concerned about vaccine safety and choose to vaccinate their children according to alternative immunization schedules," said lead study author Jason Glanz, Ph.D., a senior scientist at Kaiser Permanente's Institute for Health Research. "The medical community doesn't have a lot of data on these alternative schedules, so we are hoping the results from this study will open the door to more opportunities to examine their safety and efficacy."

The study found the number of undervaccinated children increased significantly during the study period, and 1 in 8 undervaccinated children's parents intentionally chose not to adhere to ACIP immunization guidelines. Alternative schedules either involve increasing the time between vaccinations or reducing the number of vaccinations in a single office visit, leaving children undervaccinated. Study findings also indicate undervaccinated children are less likely to visit their doctor's offices and more likely to be admitted to hospitals compared to their peers vaccinated under the standard schedule.

Kaiser Permanente can deliver transformational health research like this study in part because it has the largest private electronic health record system in the world. The organization's integrated model and electronic health record system securely connect 9 million people, 533 medical offices, and 37 hospitals, linking patients with their health care teams, their personal health information, and the latest medical knowledge. The Vaccine Safety Datalink project, which monitors immunization safety and addresses the gaps in scientific knowledge about any rare and serious events that occur following immunization, is enabled in part by Kaiser Permanente's electronic health records.

Kaiser Permanente is committed to furthering understanding of vaccine effectiveness and safety, including patterns of vaccine refusal. Recent Kaiser Permanente studies found children of parents who refuse vaccines are nine times more likely to get chickenpox and 23 times more likely to get whooping cough than fully immunized children.


'/>"/>

Contact: Catherine Hylas Saunders
csaunders@golinharris.com
202-585-2603
Kaiser Permanente
Source:Eurekalert

Related medicine news :

1. Study Finds Nearly Half of U.S. Kids Are Under-Vaccinated
2. Generic HIV treatment strategy could save nearly $1 billion annually but may be less effective
3. Nutrisystem Announces Latest Weight Loss Success Story: Life-long Fad Dieter Shari West Finds the Key to Dropping Nearly 60 Pounds*
4. Nearly One-Third of Kids With Food Allergies May Be Bullied
5. Mount Sinai survey shows that nearly 1 in 3 children with food allergies experience bullying
6. Nearly 50 Million Couples Worldwide Report Infertility
7. Consumers benefitted nearly $1.5 billion from the ACAs medical loss ratio rule in 2011
8. Predrinking Nearly Doubles Booze Consumption: Study
9. Nearly half of kidney recipients in live donor transplant chains are minorities
10. Nearly $50 million in research funding awarded by NSF
11. Pain Reported by Nearly Half With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton Business ... Award, the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... Canadian Celiac Association (CCA), is pleased to announce the launch of the ... nutritional articles, recipes, and more. The purpose of the GFCP Scoop ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... , April 28, 2016 ... Review, H1 2016" is a report that provides ... helps strengthen R&D pipelines by identifying new targets ... Company Profiles discussed in this H1 ... Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: